Key Developments: Grindeks AS (GRD1R.RI)

GRD1R.RI on Riga Stock Exchange

5.89LVL
22 Oct 2014
Price Change (% chg)

Ls -0.11 (-1.83%)
Prev Close
Ls 6.00
Open
Ls 6.00
Day's High
Ls 6.00
Day's Low
Ls 5.89
Volume
1,995
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Latest Key Developments (Source: Significant Developments)

Grindeks AS proposes dividend payment date for FY 2013
Wednesday, 24 Sep 2014 10:30am EDT 

Grindeks AS:Proposes Nov. 25 as the dividend record date and Nov. 30 as the dividend payment date for the dividend distribution of 0.52 euro per one share for the fiscal year 2013.  Full Article

Grindeks AS appoints external auditors for FY 2014
Tuesday, 10 Jun 2014 09:26am EDT 

Grindeks AS:Announces the appointment of SIA “Deloitte Audits Latvia” as the company's external auditors for the fiscal year 2014.  Full Article

Grindeks AS updates on acquisition of HBM Pharma s.r.o.
Thursday, 29 May 2014 09:50am EDT 

Grindeks AS:Informs that in 2012 there was a purchase agreement conducted with Dashdirect Limited on acquisition of 100 percent shares of HBM Pharma s.r.o. (Slovakia).Total amount of the transaction is 13.1 million euros.The company has made the advance payment of 11.67 million euros.The remaining amount of the payment will be made after the re-registration of shares to Grindeks according to Slovak legislation.It is planned that this transaction will be fully completed in 2014.After its completion HBM Pharma s.r.o. will be included in the group structure of Grindeks.Financing of purchase of shares is from the company’s funds.  Full Article

Grindeks AS updates on FY 2013 profit distribution
Tuesday, 27 May 2014 09:57am EDT 

Grindeks AS:Proposes to leave the profit for the year 2013 undistributed and to use it for the development of the company to increase its competitiveness.  Full Article

Grindeks AS recommends dividend payment for FY 2013
Monday, 19 May 2014 11:54am EDT 

Grindeks AS:Announces that the recommendation to pay in dividends to shareholders from the net profit for the year 2013 0.52 euro per one share for the fiscal year 2013.Says the total amount to be paid in dividends 4,984,200 euros.  Full Article

ABLV Private Equity Fund 2010 KS acquires 22.66 per cent shareholding in Grindeks AS
Wednesday, 5 Feb 2014 07:38am EST 

Grindeks AS:Announces that it has received the notification from the ABLV Private Equity Fund 2010 KS regarding essential acquisition of participation in the share capital of Grindeks AS in the total amount of 22.66 per cent (2,172,437shares).  Full Article

Grindeks AS Confirms FY 2013 Turnover and Profit Guidance
Wednesday, 3 Apr 2013 03:09am EDT 

Grindeks AS announced that it has confirmed its turnover and profit guidance for fiscal year 2013. As reported previously, the Company plans to reach for fiscal year 2013 turnover of approximately LVL 100 million and profit of approximately LVL 12 million.  Full Article

Grindeks AS Issues FY 2013 Turnover Guidance above Analysts’ Estimates; Issues FY 2013 Profit Guidance
Wednesday, 28 Nov 2012 07:42am EST 

Grindeks AS announced that it plans for fiscal year 2013 turnover of around LVL 100 million and profit of about LVL 12 million. According to I/B/E/S Estimates, the analysts are on average expecting the Company to report for fiscal year 2013 revenue of LVL 79.28 million.  Full Article

Grindeks AS Unveils Manufacturing Unit of Ointments and Gels
Wednesday, 28 Nov 2012 07:00am EST 

Grindeks AS announced that it has unveiled a manufacturing unit of ointments and gels. Altogether, LVL 2.5 million were invested in the manufacturing unit of ointments and gels, out of which the co-financing of the European Union structural funds is LVL 448,670. The investments are planned to be recovered within two years. The manufacturing unit of ointments and gels is equipped with devices that ensure safe, efficient and environmentally friendly production. In October 2012, the new manufacturing unit received the Certificate of Good Manufacturing Practice from the State Agency of Medicines of Latvia. The new manufacturing unit will be able to produce up to 20 million tubes per year. In the new manufacturing unit of ointments and gels of Grindeks AS, there are new job positions created for 10 qualified operators and technical engineering specialists. It is planned that the new manufacturing unit will provide also medication manufacturing for other companies according to their orders or to provide contract manufacturing services.  Full Article

Search Stocks